A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma
Launched by FRED HUTCHINSON CANCER CENTER · Apr 27, 2023
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special checklist that helps doctors understand the future mobility needs of patients with sarcoma, a type of cancer that affects the bones and soft tissues. The researchers want to see if this checklist can improve how patients plan for their future mobility after having surgery to save or remove a limb. By collecting information from patients who have undergone surgery recently or are currently receiving treatment, the study hopes to help enhance their quality of life.
To participate in this trial, you need to be 18 years or older, speak English, and have access to a computer or device to fill out an online checklist. You can join if you've had surgery for sarcoma in the last six months or if you have advanced (stage IV) sarcoma and are actively being treated. Caregivers, such as family members or friends who help support the patient, can also take part. Participants can expect to complete an online checklist that assesses their mobility needs, and this information may guide better future care for those living with sarcoma.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • PATIENTS: Age 18 years of age or older.
- • PATIENTS: English speaking
- • PATIENTS: Able to provide informed consent
- • PATIENTS: Have access to a computer or other device to fill out the online checklist
- • PATIENTS: Have had either limb salvage or amputation surgery for sarcoma within the last 6 months OR have metastatic (stage IV) sarcoma and are in active treatment.
- • CAREGIVERS: Age 18 years of age or older
- • CAREGIVERS: English speaking
- • CAREGIVERS: Able to provide informed consent
- • CAREGIVERS: Have access to a computer or other device to fill out the online checklist
- • CAREGIVERS: The person (family member or friend) whom the patient indicates being an informal caregiver
About Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center is a leading nonprofit research institution dedicated to the pursuit of innovative cancer treatments and prevention strategies. Established in Seattle, Washington, the center is renowned for its pioneering work in hematopoietic cell transplantation and its commitment to advancing cancer research through collaborative clinical trials. By integrating cutting-edge science with compassionate patient care, Fred Hutchinson Cancer Center aims to improve outcomes for patients while fostering a multidisciplinary approach to tackling complex cancer challenges. With a strong emphasis on translating research findings into clinical applications, the center is at the forefront of developing novel therapies that offer hope to patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seattle, Washington, United States
Patients applied
Trial Officials
Megan Shen
Principal Investigator
Fred Hutch/University of Washington Cancer Consortium
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported